Content about Thomas Moriarty

August 2, 2013

CVS Caremark announced on Friday that it has agreed to a $20 million civil penalty to resolve a previously disclosed investigation by the Securities and Exchange Commission into 2009 public disclosures made by the company, securities transactions and certain aspects of the purchase accounting adjustment related to the October 2008 Longs Drug Stores acquisition.

WOONSOCKET, R.I. — CVS Caremark announced on Friday that it has agreed to a $20 million civil penalty to resolve a previously disclosed investigation by the Securities and Exchange Commission into 2009 public disclosures made by the company, securities transactions and certain aspects of the purchase accounting adjustment related to the October 2008 Longs Drug Stores acquisition.

September 17, 2012

CVS Caremark has appointed Thomas Moriarty as EVP and general counsel of CVS Caremark.

WOONSOCKET, R.I. — CVS Caremark has appointed Thomas Moriarty as EVP and general counsel of CVS Caremark.

Moriarty most recently served as general counsel at the Celgene, a biopharmaceutical company, where he was responsible for global legal strategy and served on the company's management committee. Prior to that, Moriarty was general counsel and corporate secretary at Medco Health Solutions.